{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:30:09Z","timestamp":1790803809636,"version":"4.1.0"},"reference-count":49,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk0108123"],"award-info":[{"award-number":["JP20fk0108123"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Genotype V (GV) Japanese encephalitis virus (JEV) has emerged in Korea and China since 2009. Recent findings suggest that current Japanese encephalitis (JE) vaccines may reduce the ability to induce neutralizing antibodies against GV JEV compared to other genotypes. This study sought to produce a novel live attenuated JE vaccine with a high efficacy against GV JEV. Genotype I (GI)-GV intertypic recombinant strain rJEV-EXZ0934-M41 (EXZ0934), in which the E region of the GI Mie\/41\/2002 strain was replaced with that of GV strain XZ0934, was introduced with the same 10 attenuation substitutions in the E region found in the live attenuated JE vaccine strain SA 14-14-2 to produce a novel mutant virus rJEV-EXZ\/SA14142m-M41 (EXZ\/SA14142m). In addition, another mutant rJEV-EM41\/SA14142m-M41 (EM41\/SA14142m), which has the same substitutions in the Mie\/41\/2002, was also produced. The neuroinvasiveness and neurovirulence of the two mutant viruses were significantly reduced in mice. The mutant viruses induced neutralizing antibodies against GV JEV in mice. The growth of EXZ\/SA14142m was lower than that of EM41\/SA14142m. In mouse challenge tests, a single inoculation with a high dose of the mutants blocked lethal GV JEV infections; however, the protective efficacy of EXZ\/SA14142m was weaker than that of EM41\/SA14142m in low-dose inoculations. The lower protection potency of EXZ\/SA14142m may be ascribed to the reduced growth ability caused by the attenuation mutations.<\/jats:p>","DOI":"10.3390\/vaccines9101077","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T23:08:31Z","timestamp":1632784111000},"page":"1077","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Immunogenicity and Protective Ability of Genotype I-Based Recombinant Japanese Encephalitis Virus (JEV) with Attenuation Mutations in E Protein against Genotype V JEV"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1981-9062","authenticated-orcid":false,"given":"Shigeru","family":"Tajima","sequence":"first","affiliation":[{"name":"Department of Virology I, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo 162-8640, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2066-1979","authenticated-orcid":false,"given":"Satoshi","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Virology I, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo 162-8640, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0826-3513","authenticated-orcid":false,"given":"Eri","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Virology I, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo 162-8640, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6001-9278","authenticated-orcid":false,"given":"Takahiro","family":"Maeki","sequence":"additional","affiliation":[{"name":"Department of Virology I, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo 162-8640, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Inagaki","sequence":"additional","affiliation":[{"name":"Department of Virology I, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo 162-8640, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5458-7298","authenticated-orcid":false,"given":"Masayuki","family":"Saijo","sequence":"additional","affiliation":[{"name":"Department of Virology I, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo 162-8640, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5823-8300","authenticated-orcid":false,"given":"Chang Kweng","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Virology I, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo 162-8640, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0264-410X(00)00037-2","article-title":"New initiatives for the control of Japanese encephalitis by vaccination: Minutes of a WHO\/CVI meeting, Bangkok, Thailand, 13\u201315 October 1998","volume":"18","author":"Tsai","year":"2000","journal-title":"Vaccine"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid1501.080311","article-title":"Past, present, and future of Japanese encephalitis","volume":"15","author":"Erlanger","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: A systematic review","volume":"89","author":"Campbell","year":"2011","journal-title":"Bull. World Health Organ."},{"key":"ref_4","unstructured":"David, M.K., and Peter, M.H. (2013). Flaviviruses. Fields Virology, Lippincott Williams & Wilkins. [6th ed.]."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4269\/ajtmh.2001.65.242","article-title":"Phylogenetic analysis of Japanese encephalitis virus: Envelope gene based analysis reveals a fifth genotype, geographic clustering, and multiple introductions of the virus into the Indian subcontinent","volume":"65","author":"Uchil","year":"2001","journal-title":"Am. J. Trop Med. Hyg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/JVI.77.5.3091-3098.2003","article-title":"Origin and evolution of Japanese encephalitis virus in southeast Asia","volume":"77","author":"Solomon","year":"2003","journal-title":"J. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Gao, X., Liu, H., Wang, H., Fu, S., Guo, Z., and Liang, G. (2013). Southernmost Asia is the source of Japanese encephalitis virus (genotype 1) diversity from which the viruses disperse and evolve throughout Asia. PLoS Negl. Trop Dis., 7.","DOI":"10.1371\/journal.pntd.0002459"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1128\/JVI.02686-13","article-title":"Dynamics of the Emergence and Establishment of a Newly Dominant Genotype of Japanese Encephalitis Virus throughout Asia","volume":"88","author":"Schuh","year":"2014","journal-title":"J. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41182-016-0010-0","article-title":"Molecular and serological epidemiology of Japanese encephalitis virus (JEV) in a remote island of western Japan: An implication of JEV migration over the East China Sea","volume":"44","author":"Yoshikawa","year":"2016","journal-title":"Trop Med. Health"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Hameed, M., Wahaab, A., Nawaz, M., Khan, S., Nazir, J., Liu, K., Wei, J., and Ma, Z. (2021). Potential Role of Birds in Japanese Encephalitis Virus Zoonotic Transmission and Genotype Shift. Viruses, 13.","DOI":"10.20944\/preprints202101.0549.v1"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/vbz.2011.0870","article-title":"Genetic diversity of Japanese encephalitis virus isolates obtained from the Indonesian archipelago between 1974 and 1987","volume":"13","author":"Schuh","year":"2013","journal-title":"Vector Borne. Zoonotic Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3201\/eid2601.190235","article-title":"Distribution of Japanese Encephalitis Virus, Japan and Southeast Asia, 2016\u20132018","volume":"26","author":"Kuwata","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Li, M.H., Fu, S.H., Chen, W.X., Wang, H.Y., Guo, Y.H., Liu, Q.Y., Li, Y.X., Luo, H.M., Da, W., and Duo Ji, D.Z. (2011). Genotype v Japanese encephalitis virus is emerging. PLoS Negl. Trop Dis., 5.","DOI":"10.1371\/journal.pntd.0001231"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kim, H., Cha, G.W., Jeong, Y.E., Lee, W.G., Chang, K.S., Roh, J.Y., Yang, S.C., Park, M.Y., Park, C., and Shin, E.H. (2015). Detection of Japanese encephalitis virus genotype V in Culex orientalis and Culex pipiens (Diptera: Culicidae) in Korea. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116547"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/1743-422X-8-449","article-title":"Emergence of Japanese encephalitis virus genotype V in the Republic of Korea","volume":"8","author":"Takhampunya","year":"2011","journal-title":"Virol. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.3346\/jkms.2018.33.e70","article-title":"Changes of Epidemiological Characteristics of Japanese Encephalitis Viral Infection and Birds as a Potential Viral Transmitter in Korea","volume":"33","author":"Bae","year":"2018","journal-title":"J. Korean Med. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3201\/eid2605.190977","article-title":"Genetic Characterization of Japanese Encephalitis Virus Genotype 5 Isolated from Patient, South Korea, 2015","volume":"26","author":"Woo","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1128\/JVI.00358-15","article-title":"A Japanese Encephalitis virus genotype 5 molecular clone is highly neuropathogenic in a mouse model: Implication of the structural proteins region in virulence","volume":"89","author":"Frenkiel","year":"2015","journal-title":"J. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1099\/vir.0.000213","article-title":"In vitro growth, pathogenicity and serological characteristics of the Japanese encephalitis virus genotype V Muar strain","volume":"96","author":"Tajima","year":"2015","journal-title":"J. Gen. Virol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Cao, L., Fu, S., Gao, X., Li, M., Cui, S., Li, X., Cao, Y., Lei, W., Lu, Z., and He, Y. (2016). Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus. PLoS Negl. Trop Dis., 10.","DOI":"10.1371\/journal.pntd.0004686"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e02882","DOI":"10.1016\/j.heliyon.2019.e02882","article-title":"E and prM proteins of genotype V Japanese encephalitis virus are required for its increased virulence in mice","volume":"5","author":"Tajima","year":"2019","journal-title":"Heliyon"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Tajima, S., Taniguchi, S., Nakayama, E., Maeki, T., Inagaki, T., Lim, C.K., and Saijo, M. (2020). Amino Acid at Position 166 of NS2A in Japanese Encephalitis Virus (JEV) is Associated with In Vitro Growth Characteristics of JEV. Viruses, 12.","DOI":"10.3390\/v12070709"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7883\/yoken.JJID.2018.126","article-title":"Comparison of Neutralizing Antibody Titers against Japanese Encephalitis Virus Genotype V Strain with Those against Genotype I and III Strains in the Sera of Japanese Encephalitis Patients in Japan in 2016","volume":"71","author":"Maeki","year":"2018","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.7883\/yoken.JJID.2018.232","article-title":"Neutralization Potency of Sera from Vietnamese Patients with Japanese Encephalitis (JE) against Genotypes I and V JE Viruses","volume":"72","author":"Nguyen","year":"2019","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.4161\/21645515.2014.980197","article-title":"Immunogenicity and safety of currently available Japanese encephalitis vaccines: A systematic review","volume":"10","author":"Li","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s40506-020-00242-5","article-title":"Japanese Encephalitis Vaccines","volume":"12","author":"Satchidanandam","year":"2020","journal-title":"Curr. Treat Options Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.vaccine.2014.10.004","article-title":"Live virus vaccines based on a yellow fever vaccine backbone: Standardized template with key considerations for a risk\/benefit assessment","volume":"33","author":"Monath","year":"2015","journal-title":"Vaccine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1016\/j.vaccine.2010.02.105","article-title":"Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities","volume":"28","author":"Yu","year":"2010","journal-title":"Vaccine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/infdis\/171.5.1144","article-title":"Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA","volume":"171","author":"Sumiyoshi","year":"1995","journal-title":"J. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1099\/0022-1317-77-7-1449","article-title":"Molecular differences between wild-type Japanese encephalitis virus strains of high and low mouse neuroinvasiveness","volume":"77","author":"Ni","year":"1996","journal-title":"J. Gen. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1099\/vir.0.80638-0","article-title":"Characterization of the E-138 (Glu\/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone","volume":"86","author":"Zhao","year":"2005","journal-title":"J. Gen. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1016\/j.vaccine.2009.03.007","article-title":"A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability","volume":"27","author":"Liang","year":"2009","journal-title":"Vaccine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1128\/JVI.00219-15","article-title":"Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice","volume":"89","author":"Gromowski","year":"2015","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Yang, J., Yang, H., Li, Z., Wang, W., Lin, H., Liu, L., Ni, Q., Liu, X., Zeng, X., and Wu, Y. (2017). Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain. Viruses, 9.","DOI":"10.3390\/v9010020"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e00108-18","DOI":"10.1128\/JVI.00108-18","article-title":"Acidity\/Alkalinity of Japanese Encephalitis Virus E Protein Residue 138 Alters Neurovirulence in Mice","volume":"92","author":"Zheng","year":"2018","journal-title":"J. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00705-018-3765-2","article-title":"Mutation of I176R in the E coding region weakens Japanese encephalitis virus neurovirulence, but not its growth rate in BHK-21 cells","volume":"163","author":"Zhou","year":"2018","journal-title":"Arch. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Anwar, M.N., Wang, X., Hameed, M., Wahaab, A., Li, C., Sharma, M., Pang, L., Malik, M.I., Liu, K., and Li, B. (2020). Phenotypic and Genotypic Comparison of a Live-Attenuated Genotype I Japanese Encephalitis Virus SD12-F120 Strain with Its Virulent Parental SD12 Strain. Viruses, 12.","DOI":"10.3390\/v12050552"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1099\/vir.0.82941-0","article-title":"Molecular epidemiological analyses of Japanese encephalitis virus isolates from swine in Japan from 2002 to 2004","volume":"88","author":"Nerome","year":"2007","journal-title":"J. Gen. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.virol.2009.10.035","article-title":"A single mutation in the Japanese encephalitis virus E protein (S123R) increases its growth rate in mouse neuroblastoma cells and its pathogenicity in mice","volume":"396","author":"Tajima","year":"2010","journal-title":"Virology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jviromet.2005.02.001","article-title":"Detection of West Nile virus and Japanese encephalitis virus using real-time PCR with a probe common to both viruses","volume":"126","author":"Shirato","year":"2005","journal-title":"J. Virol. Methods"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Yun, S.I., Song, B.H., Kim, J.K., Yun, G.N., Lee, E.Y., Li, L., Kuhn, R.J., Rossmann, M.G., Morrey, J.D., and Lee, Y.M. (2014). A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: A conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004290"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0264-410X(00)00041-4","article-title":"Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains","volume":"18","author":"Kurane","year":"2000","journal-title":"Vaccine"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1099\/0022-1317-68-3-853","article-title":"Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1","volume":"68","author":"Schlesinger","year":"1987","journal-title":"J. Gen. Virol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1099\/0022-1317-71-8-1697","article-title":"Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b","volume":"71","author":"Putnak","year":"1990","journal-title":"J. Gen. Virol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e02494-19","DOI":"10.1128\/mBio.02494-19","article-title":"A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies","volume":"11","author":"Mishra","year":"2020","journal-title":"mBio"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.virusres.2014.10.010","article-title":"Construction of an infectious molecular clone of Japanese encephalitis virus genotype V and its derivative subgenomic replicon capable of expressing a foreign gene","volume":"195","author":"Ishikawa","year":"2015","journal-title":"Virus. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.virol.2015.10.015","article-title":"Development of a human live attenuated West Nile infectious DNA vaccine: Suitability of attenuating mutations found in SA14-14-2 for WN vaccine design","volume":"487","author":"Yamshchikov","year":"2016","journal-title":"Virology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax-West Nile virus live-attenuated vaccine: Preclinical evaluation of safety, immunogenicity, and efficacy","volume":"78","author":"Arroyo","year":"2004","journal-title":"J. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41541-019-0146-0","article-title":"Japanese encephalitis vaccine-specific envelope protein E138K mutation does not attenuate virulence of West Nile virus","volume":"4","author":"Kaiser","year":"2019","journal-title":"NPJ Vaccines"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/10\/1077\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:04:55Z","timestamp":1760166295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/10\/1077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,25]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["vaccines9101077"],"URL":"https:\/\/doi.org\/10.3390\/vaccines9101077","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,25]]}}}